Gisela Schwab Insider Profile
11 Followers
Gisela Schwab, Pres, Prod Dev & Med Aff & CMO at Exelixis, holds 703.96K shares in Exelixis (Ticker: EXEL), holds ― shares in Genocea Biosciences (Ticker: GNCAQ).
Gisela Schwab's Trading History
| EXELExelixis | Jul 28, 2021 | Pres, Prod Dev & Med Aff & CMO | Uninformative Buy | 168.00K | $47.24M | |
| GNCAQGenocea Biosciences | ― | ― | ― | ― |
You May Also Like
Gisela Schwab insider profile FAQ
What is the percentage of profitable transactions made by Gisela Schwab?
The percentage of profitable transactions made by Gisela Schwab is 60%.
What is the average return per transaction made by Gisela Schwab?
The average return per transaction made by Gisela Schwab is 2.70%.
What stocks does Gisela Schwab hold?
Gisela Schwab holds: EXEL, GNCAQ stocks.
What was Gisela Schwab’s latest transaction?
Gisela Schwab’s latest transaction was an Uninformative Buy of $168.00K.
What was Gisela Schwab's most profitable transaction?
Gisela Schwab’s most profitable transaction was an Informative Sell of EXEL stock on September 28, 2017. The return on the trade was 26.80%.
What is Gisela Schwab's role in Exelixis?
Gisela Schwab's role in Exelixis is Pres, Prod Dev & Med Aff & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
